Target intelligence / Profile preview

Inflammatory cytokine system and C-fiber afferent neuron pathways

Molecular classification
Signaling pathway, Neuro-immune system, Cytokine system
01

Overview

The inflammatory cytokine system and C-fiber afferent neuron pathways represent a complex neuro-immune axis critical for the development of chronic pain and inflammation (Zhang & An, 2007, PMID: 17426506). Pro-inflammatory cytokines such as TNF-alpha, IL-1 beta, and IL-6 are released by activated immune cells and act on receptors expressed on the peripheral terminals of unmyelinated C-fiber nociceptors (Sommer & Kress, 2004, PMID: 15257338). This interaction leads to peripheral sensitization by modulating the activity of ion channels like TRPV1 and voltage-gated sodium channels (Nav1.7, Nav1.8), which lowers the threshold for neuronal firing and amplifies pain signals (Uceyler et al., 2009, PMID: 19444956). This pathway is a major driver in diseases such as rheumatoid arthritis, neuropathic pain, and fibromyalgia. Therapeutic interventions targeting this system, such as TNF inhibitors or IL-1 blockers, aim to interrupt this crosstalk to reduce pain hypersensitivity and tissue damage (Schafers et al., 2003, PMID: 12843211). By neutralizing these cytokines, drugs can effectively decouple the immune response from the sensory nervous system, providing relief for patients with chronic inflammatory conditions.

Other names
Neuro-immune axisCytokine-nociceptor signaling pathwayPeripheral sensitization pathwayNeuroinflammatory pain pathwayCytokine-mediated nociception
02

Mechanism of action

Neutralization of pro-inflammatory cytokines (e.g., TNF-alpha, IL-1, IL-6) or blockade of their respective receptors to prevent the sensitization and activation of C-fiber nociceptors (Sommer & Kress, 2004, PMID: 15257338; Zhang & An, 2007, PMID: 17426506).

03

Biological functions

NociceptionImmune responseSignal transductionInflammationSensory perception
04

Disease associations

Chronic painNeuropathic painRheumatoid arthritisFibromyalgiaInflammatory bowel diseaseComplex regional pain syndrome
05

Safety considerations

Increased risk of serious infectionsImmunosuppressionInjection site reactionsPotential for malignancy with long-term cytokine inhibitionNeurological side effectsDemyelinating disease (rarely associated with TNF inhibitors)
06

Interacting drugs

Infliximab

7 more in the full profile.

07

Biomarkers

Tumor necrosis factor-alpha (TNF-alpha)Interleukin-1 beta (IL-1β)Interleukin-6 (IL-6)C-reactive protein (CRP)Nerve growth factor (NGF)Substance P

Beyond the preview

Go deeper on Inflammatory cytokine system and C-fiber afferent neuron pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inflammatory cytokine system and C-fiber afferent neuron pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call